rifampin double dose

DRUG2 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre

Conditions

Latent TuberculosisTuberculosis Infection, Latent

Phase 2

2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

CompletedNCT03988933

McGill University Health Centre/Research Institute of the McGill University Health CentreLatent Tuberculosis

Start: 2019-09-20End: 2024-12-31Updated: 2026-04-13

Shorter and Safer Treatment Regimens for Latent TB

RecruitingNCT06498414

McGill University Health Centre/Research Institute of the McGill University Health CentreTuberculosis Infection, Latent

Start: 2025-06-10End: 2029-06-01Target: 1800Updated: 2026-05-11

Related Papers

High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial.

2024-03-269 citations

High dose rifampin for 2 months vs standard dose rifampin for 4 months, to treat TB infection: Protocol of a 3-arm randomized trial (2R2)

PLoS ONE2023-02-023 citations